Why subscribe?
Alzheimer’s research in plain English. What’s new, what’s hype, and which trials to watch.
I started Alzheimer’s for Amateurs to keep up with the research for myself. Then the project got a little out of hand. It’s become one of the most useful tools I have for my own health decisions, so I’m sharing it.
Why it exists
Something shows promise, like a supplement or a new drug. A trial starts. Life goes on, and you miss the result that could have helped you, or told you to stop.
This newsletter follows those leads until the data comes in, and tells you what it says, whichever way it goes. A full Trial Watch feature is coming soon.
What you’ll get
Each edition leads with one story worth your time, then a quick roundup of new research, the trials to watch, and the products people are talking about. All in plain English, for anyone with Alzheimer’s somewhere in their life. That’s a lot of us.
How it’s made
This is an AI project. It began as a weekly AI automation that summarized Alzheimer’s research. Then I combined it with Andrej Karpathy’s autoresearch idea, and it grew into a self-updating research library.
AI researchers comb through Alzheimer’s news every week. An AI writer, editors and proofreaders turn it into editions. I’m the editor, and nothing goes out without my yes.
Two places to look around:
How it’s made: the whole process, start to finish.
Research Index: every study and trial I’ve covered, in one place.
About me
I’m Tony Rosen. As the name says, I’m an amateur: not a doctor or a scientist, just someone who wants to know what’s actually working.
If you know someone who’d find this useful, please pass it along:

